56 research outputs found

    ๋งˆ์ด์ฝ”ํ”Œ๋ผ์ฆˆ๋งˆ ํ•˜์ด์˜ค๋‰ด๋ชจ๋‹ˆ์•  ๋ฐ•ํ…Œ๋ฆฐ ๋ฐฑ์‹  ํšจ๋Šฅ์˜ ๋ฏธ์ƒ๋ฌผํ•™์ , ๋ฉด์—ญํ•™์ , ๋ณ‘๋ฆฌํ•™์  ํ‰๊ฐ€

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ(๋ฐ•์‚ฌ) -- ์„œ์šธ๋Œ€ํ•™๊ต๋Œ€ํ•™์› : ์ˆ˜์˜๊ณผ๋Œ€ํ•™ ์ˆ˜์˜ํ•™๊ณผ, 2023. 2. ์ฑ„์ฐฌํฌ.Mycoplasma hyopneumoniae๋Š” ๋ผ์ง€์—์„œ ์ผ์ฐจ์ ์œผ๋กœ๋Š” ์œ ํ–‰์„ฑ ํ๋ ด(enzootic pneumonia)์„ ์ผ์œผํ‚ค๋Š” ๋ณ‘์›์ฒด์ด๋ฉฐ, ๊ฐ์—ผ ์‹œ ํ˜ธํก๊ธฐ๋„ ์ƒํ”ผ์„ธํฌ์™€ ์„ฌ๋ชจ๋ฅผ ํŒŒ๊ดดํ•˜์—ฌ 2์ฐจ์ ์ธ ์„ธ๊ท ์ด๋‚˜ ๋ฐ”์ด๋Ÿฌ์Šค ๊ฐ์—ผ์„ ์œ ๋ฐœํ•˜๋ฏ€๋กœ ๋ผ์ง€ํ˜ธํก๊ธฐ๋ณตํ•ฉ๊ฐ์—ผ์ฆ(PRDC, Porcine Respiratory Disease Complex)์˜ ๋ณ‘์ธํ•™์—์„œ ๋งค์šฐ ์ค‘์š”ํ•œ ์œ„์น˜๋ฅผ ์ฐจ์ง€ํ•œ๋‹ค. ์–‘๋ˆ ์‚ฐ์—…์— ์žˆ์–ด์„œ M. hyopneumoniae๋Š” ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ์œ ๋ณ‘๋ฅ ์ด ๋†’๊ณ , ์„ฑ์žฅ ์ •์ฒด ๋ฐ ์‚ฌ๋ฃŒ ํšจ์œจ ์ €ํ•˜๋ฅผ ์œ ๋ฐœํ•˜์—ฌ ๋†๊ฐ€์— ์‹ฌ๊ฐํ•œ ๊ฒฝ์ œ์  ์†์‹ค์„ ์ฃผ๊ณ  ์žˆ๋‹ค. ์ง€๊ธˆ๊นŒ์ง€ M. hyopneumoniae๋ฅผ ํ†ต์ œํ•˜๊ณ  ์˜ˆ๋ฐฉํ•˜๊ธฐ ์œ„ํ•œ ์—ฌ๋Ÿฌ ๋…ธ๋ ฅ์ด ์žˆ์—ˆ์œผ๋‚˜ ์ˆ˜ ํ‚ฌ๋กœ๋ฏธํ„ฐ์— ๊ฑธ์นœ ๊ณต๊ธฐ ์ „ํŒŒ๊ฐ€ ๊ฐ€๋Šฅํ•œ ๋ณ‘์›์ฒด์˜ ํŠน์„ฑ๊ณผ ์–‘๋ˆ ๋†๊ฐ€์˜ ๋ฐ€์ง‘ ์‚ฌ์œก ๊ด€ํ–‰์œผ๋กœ ์ธํ•˜์—ฌ M. hyopneumoniae์˜ ๋ฐ•๋ฉธ ๋ฐ ์ฒญ์ •์ƒํƒœ์˜ ์œ ์ง€๋Š” ๋งค์šฐ ์–ด๋ ต๋‹ค. ๋”ฐ๋ผ์„œ ๋ฐฑ์‹  ์ ‘์ข…์ด M. hyopneumoniae ๊ฐ์—ผ์„ ํ†ต์ œํ•  ์ˆ˜ ์žˆ๋Š” ๊ฐ€์žฅ ํšจ์œจ์ ์ธ ์ˆ˜๋‹จ์œผ๋กœ ๊ฐ„์ฃผ๋œ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ๋ชฉ์ ์€ ์ƒˆ๋กœ์šด ๋ผ์ง€ M. hyopneumoniae bacterin ๋ฐฑ์‹ ์˜ ํ•œ๊ตญ ๋„์ž…์„ ์œ„ํ•ด ์‹คํ—˜์ ์œผ๋กœ ์œ ๋„ํ•œ M. hyopneumoniae ๊ฐ์—ผ ๋ชจ๋ธ๊ณผ ๊ตญ๋‚ด ์•ผ์™ธ ํ™˜๊ฒฝ์—์„œ ๋ฐฑ์‹ ์˜ ํšจ๋Šฅ๊ณผ ์•ˆ์ „์„ฑ์„ ์ž„์ƒํ•™์ , ๋ฏธ์ƒ๋ฌผํ•™์ , ๋ฉด์—ญํ•™์ , ๋ณ‘๋ฆฌํ•™์  ๊ธฐ๋ฒ•์œผ๋กœ ๋ถ„์„ํ•˜๋Š” ๊ฒƒ์ด๋‹ค. ๋ฐฑ์‹ ์˜ ํšจ๋Šฅ์€ M. hyopneumoniae์˜ ๋น„๊ฐ• ๋ฐฐ์ถœ์„ ํ†ตํ•ด ๋ฏธ์ƒ๋ฌผํ•™์ ์œผ๋กœ ํ‰๊ฐ€ํ•˜์˜€์œผ๋ฉฐ, ๋˜ํ•œ ๋ฉด์—ญํ•™์ ์œผ๋กœ๋Š” ELISA์™€ ์ธํ„ฐํŽ˜๋ก  ๊ฐ๋งˆ ๋ถ„๋น„์„ธํฌ(IFN-ฮณ-SC) ์ˆ˜์˜ ์ธก์ •์„ ํ†ตํ•ด ์ฒด์•ก์„ฑ ๋ฉด์—ญ ๋ฐ ์„ธํฌ ๋งค๊ฐœ์„ฑ ๋ฉด์—ญ ํšจ๋Šฅ์„ ํ‰๊ฐ€ํ•˜์˜€๋‹ค. ํ์˜ ์œก์•ˆ๋ณ‘๋ณ€๊ณผ ์กฐ์ง๋ณ‘๋ณ€์„ ์ ์ˆ˜ํ™”ํ•˜์—ฌ ๋ณ‘๋ฆฌํ•™์  ํ‰๊ฐ€๋ฅผ ํ•˜์˜€๋‹ค. ๋ฐฑ์‹ ์˜ ์•ˆ์ „์„ฑ์€ ํ˜ธํก๊ธฐ ์งˆํ™˜์— ๋Œ€ํ•œ ์ž„์ƒ์ ์ธ ํ‰๊ฐ€์™€ ์ผ๋‹น ์ฆ์ฒด์œจ์„ ์ง€ํ‘œ๋กœ ํ‰๊ฐ€ํ•˜์˜€๋‹ค. ์ฒซ ๋ฒˆ์งธ ์‹คํ—˜์—์„œ๋Š” ์‹คํ—˜์‹ค ์กฐ๊ฑด์—์„œ ๊ตญ๋‚ด ๋ณ‘์›์„ฑ M. hyopneumoniae ๋ถ„๋ฆฌ์ฃผ๋ฅผ ์‚ฌ์šฉํ•œ ๊ฐ์—ผ ๋ชจ๋ธ์—์„œ ๋ฐฑ์‹ ์˜ ํšจ๋Šฅ์„ ํ‰๊ฐ€ํ•˜์˜€๋‹ค. ์‹คํ—˜ ๊ฒฐ๊ณผ, ๋ฐฑ์‹ ์„ ์ ‘์ข…ํ•œ ๊ทธ๋ฃน์€ ์ ‘์ข…ํ•˜์ง€ ์•Š์€ ๊ทธ๋ฃน์— ๋น„ํ•ด M. hyopneumoniae ํŠน์ด์ ์ธ ELISA ํ•ญ์ฒด์™€ IFN-ฮณ-SC๋ฅผ ์œ ์˜์ ์œผ๋กœ ๋” ๋งŽ์ด ์œ ๋„ํ•˜์˜€๋‹ค. M. hyopneumoniae์˜ ๋น„๊ฐ• ๋ฐฐ์ถœ๊ณผ ํ ๋ณ‘๋ณ€ ๋ถ„์„์—์„œ๋„ ๋ฐฑ์‹ ์„ ์ ‘์ข…ํ•œ ๊ทธ๋ฃน์ด ๊ทธ๋ ‡์ง€ ์•Š์€ ๊ทธ๋ฃน์— ๋น„ํ•ด ์œ ์˜์ ์œผ๋กœ ๋‚ฎ์€ ์ˆ˜์ค€์„ ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ ํ‰๊ฐ€๋œ ๋ฐฑ์‹ ์€ ๊ตญ๋‚ด ๋ณ‘์›์„ฑ M. hyopneumoniae ๋ถ„๋ฆฌ์ฃผ์˜ ๊ฐ์—ผ ์ปจํŠธ๋กค์—๋„ ํšจ๊ณผ์ ์ธ ๊ฒƒ์œผ๋กœ ํŒ๋‹จ๋˜์—ˆ๋‹ค. ๋‘ ๋ฒˆ์งธ ์‹คํ—˜์—์„œ๋Š” ๋ผ์ง€ ์œ ํ–‰์„ฑ ํ๋ ด ์ง„๋‹จ ์ด๋ ฅ์ด ์žˆ๋Š” ๊ตญ๋‚ด ์–‘๋ˆ ๋†์žฅ 3๊ฐœ์†Œ์—์„œ ๋ฐฑ์‹ ์˜ ํšจ๋Šฅ๊ณผ ์•ˆ์ „์„ฑ์„ ํ‰๊ฐ€ํ•˜์˜€๋‹ค. ์‹คํ—˜ ๊ฒฐ๊ณผ, 3๊ฐœ ๋†์žฅ ๋ชจ๋‘ ๋ฐฑ์‹ ์„ ์ ‘์ข…ํ•œ ๊ทธ๋ฃน์€ ์ ‘์ข…ํ•˜์ง€ ์•Š์€ ๊ทธ๋ฃน์— ๋น„ํ•ด ํ˜ธํก๊ธฐ ์ž„์ƒ ์ฆ์ƒ์ด ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์•˜์œผ๋ฉฐ, ์ฆ์ฒด์œจ์€ ์œ ์˜ํ•˜๊ฒŒ ๋†’์•˜๋‹ค. ๋˜ํ•œ 3๊ฐœ ๋†์žฅ ๋ชจ๋‘ ๋ฐฑ์‹ ์„ ์ ‘์ข…ํ•œ ๊ทธ๋ฃน์—์„œ ๋ฐฑ์‹ ์„ ์ ‘์ข…ํ•˜์ง€ ์•Š์€ ๊ทธ๋ฃน์— ๋น„ํ•ด M. hyopneumoniae ํŠน์ด์ ์ธ IFN-ฮณ-SC๊ฐ€ ์œ ์˜์ ์œผ๋กœ ๋” ๋งŽ์ด ์œ ๋„๋˜์—ˆ์œผ๋ฉฐ, ํ ๋ณ‘๋ณ€์˜ ์ค‘์ฆ๋„๋Š” ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์•˜๋‹ค. ๋”ฐ๋ผ์„œ ํ‰๊ฐ€๋œ ๋ฐฑ์‹ ์ด M. hyopneumoniae ๋ณ‘์›์ฒด๊ฐ€ ์ƒ์žฌํ•œ ํ™˜๊ฒฝ์—์„œ ์„ธํฌ ๋งค๊ฐœ ๋ฉด์—ญ์„ ํšจ๊ณผ์ ์œผ๋กœ ์œ ๋„ํ•˜๊ณ , ํ ๋ณ‘๋ณ€์˜ ์ค‘์ฆ๋„์™€ ํ˜ธํก๊ธฐ ์ž„์ƒ ์ฆ์ƒ์„ ์™„ํ™”์‹œ์ผœ ์ฆ์ฒด์œจ์„ ํšจ๊ณผ์ ์œผ๋กœ ํ–ฅ์ƒ์‹œ์ผฐ์Œ์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋‘ ๊ฐ€์ง€ ์‹คํ—˜์—์„œ ์ƒˆ๋กœ์šด ๋ผ์ง€ M. hyopneumoniae bacterin ๋ฐฑ์‹ ์„ ์ž„์ƒํ•™์ , ๋ฏธ์ƒ๋ฌผํ•™์ , ๋ฉด์—ญํ•™์ , ๋ณ‘๋ฆฌํ•™์  ๊ธฐ๋ฒ•์œผ๋กœ ํ‰๊ฐ€ํ•˜์˜€์œผ๋ฉฐ, ๊ทธ ๊ฒฐ๊ณผ ๊ตญ๋‚ด ๋ณ‘์›์„ฑ ๋ถ„๋ฆฌ์ฃผ์— ๋Œ€ํ•ด์„œ๋„ ํšจ๊ณผ์ ์ธ ๋ฐฉ์–ด๋Šฅ์„ ํ™•์ธํ•˜์˜€๊ณ , ์•ผ์™ธ ํ™˜๊ฒฝ์—์„œ ์ ์šฉํ•˜์˜€์„ ๋•Œ ๊ฐœ์„ ๋œ ์ฆ์ฒด์œจ์„ ํ™•์ธํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ƒˆ๋กœ์šด ๋ผ์ง€ M. hyopneumoniae bacterin ๋ฐฑ์‹ ์€ M. hyopneumoniae ๊ฐ์—ผ์„ ํ†ต์ œํ•  ์ˆ˜ ์žˆ๋Š” ๋˜ ํ•˜๋‚˜์˜ ์„ ํƒ์ง€๋ฅผ ์ œ๊ณตํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, M. hyopneumoniae๊ฐ€ ๋ผ์ง€ํ˜ธํก๊ธฐ๋ณตํ•ฉ๊ฐ์—ผ์ฆ์—์„œ 1์ฐจ ๋ณ‘์›์ฒด์˜ ์—ญํ• ์„ ํ•˜๊ณ , ์–‘๋ˆ ๋†๊ฐ€์— ์‹ฌ๊ฐํ•œ ๊ฒฝ์ œ์  ํƒ€๊ฒฉ์„ ์ฃผ๋Š” ์ ์„ ๊ณ ๋ คํ•  ๋•Œ ์ด๋Š” ๋™๋ฌผ๋ณต์ง€์™€ ์–‘๋ˆ ์‚ฐ์—…์˜ ์ง€์†์ ์ธ ์„ฑ์žฅ์— ๋งค์šฐ ์ค‘์š”ํ•œ ์‹œ์‚ฌ์ ์„ ์ค€๋‹ค.Mycoplasma hyopneumoniae is the primary pathogenic agent of enzootic pneumonia in pigs, and it becomes very important in the etiology of the porcine respiratory disease complex (PRDC) as it gives damage to the ciliated epithelium of the trachea, bronchi, and bronchioles so makes pig susceptible to secondary bacterial and viral invaders. In the pig industry, M. hyopneumoniae is a high prevalent worldwide, causes significant economic losses to farms resulting from growth retardation and poor feed efficiency. Although there have been many efforts to control and prevent M. hyopneumoniae, it is very difficult to eradicate and maintain M. hyopneumoniae free due to the nature of airborne pathogens can spread several kilometers and the dense breeding practices of pig farms. Therefore, vaccination is considered the most efficient tool of controlling M. hyopneumoniae. The purpose of this study is to analyze the efficacy and safety of the new single-dose inactivated M. hyopneumoniae bacterin in Korean field and laboratory condition using a clinical, microbiological, immunological, and pathological technique. The efficacy of the vaccine was evaluated microbiologically through the nasal shedding of M. hyopneumoniae and was assessed humoral and cell-mediated immunity through enzyme-linked immunosorbent assay (ELISA) and measuring the number of interferon gamma secreting cells (IFN-ฮณ-SC) in peripheral blood mononuclear cells (PBMC). Pathological evaluation was performed by the observation of gross and microscopic in lung lesion, and the isolation of M. hyopneumoniae antigen in the lesion. The safety of the vaccine was evaluated as an index for clinical evaluation of respiratory diseases and average of daily weight gain (ADWG). Chapter I is with the efficacy evaluation of the vaccine under laboratory condition using challenge model of Korean pathogenic M. hyopneumoniae isolate. As a result of the experiment, the vaccinated group significantly induced more M. hyopneumoniae-specific ELISA antibodies and IFN-ฮณ-SC in PBMC compared to the unvaccinated. The nasal shedding and lung lesion analysis of M. hyopneumoniae also showed significantly lower levels in the vaccinated group than the unvaccinated. Therefore, the vaccine is considered to be effective in controlling infection of Korean pathogenic M. hyopneumoniae isolates. Chapter II is with the evaluation of efficacy and safety of the vaccine at three commercial pig farms with a history of swine enzootic pneumonia in Korea. As a result of the experiment, the vaccinated groups in all three farms had significantly lower respiratory clinical symptom, and the higher average of daily weight gain than the unvaccinated groups. Furthermore, in all three farms, the vaccinated group significantly induced more M. hyopneumoniae-specific IFN-ฮณ-SC than the unvaccinated group. The severity of lung lesions of the vaccinated groups was significantly lower than that of the unvaccinated groups. Therefore, it was confirmed that the vaccine effectively induced cell-mediated immunity in the environment in which the M. hyopneumoniae pathogen is present, and effectively improved the daily weight gain by alleviating the severity of lung lesions and respiratory clinical symptoms. Above two series studies, the new single-dose inactivated M. hyopneumoniae bacterin was assessed for clinical, microbiological, immunological, and pathological parameters. The vaccine demonstrated the protection ability against challenging domestic pathogenic isolates, and the improved daily weight gain was confirmed when applied in field condition. The new single-dose inactivated M. hyopneumoniae whole-cell bacterin can provide another option to control M. hyopneumoniae and considering that it is the primary agent for the Porcine Respiratory Disease Complex and causing a severe economic impact to swine farmers, this can suggest an important implication to sustainable growth in animal welfare and the swine production industry.GENERAL INTRODUCTION 1 LITERATURE REVIEW โ€“ Mycoplasma hyopneumoniae 3 1. Introduction 3 2. Etiology 5 3. Pathogenesis 7 4. Swine enzootic pneumonia 10 5. Porcine respiratory disease complex 12 6. Epidemiology 14 7. Immunity 18 8. Vaccine 21 9. References 27 CHAPTER I. Experimental evaluation of Mycoplasma hyopneumoniae bacterin against a Korean M. hyopneumoniae challenge 48 1. Abstract 49 2. Introduction 50 3. Materials and Methods 51 4. Results 56 5. Discussion 63 6. References 65 CHAPTER II. Field evaluation of a new single-dose Mycoplasma hyopneumoniae bacterin effects on growth performance 69 1. Abstract 70 2. Introduction 71 3. Methods 72 4. Results 79 5. Discussion 91 6. References 95 GENERAL CONCLUSION 101 ABSTRACT IN KOREAN 104๋ฐ•

    ์‹œ์žฅ๊ฒฝ์ œ์™€ ์ค‘์†Œ๊ทœ๋ชจํ˜‘๋™์กฐํ•ฉ์˜ ์—ญํ• ๋ถ„์„ ๋ฐ ์ •์ฑ… ์ œ์–ธ

    Get PDF
    ์ด ๊ธ€์€ ์ €์ž‘๊ถŒ์ž์˜ ์Šน๋ฝ์„ ์–ป์–ด ๋‹จํ–‰๋ณธ ใ€Žํ•œ๊ตญํ˜• ์‹œ์žฅ ๊ฒฝ์ œ์ฒด์ œใ€(2014๋…„, ์ด์˜ํ›ˆ ํŽธ, ์„œ์šธ๋Œ€ํ•™๊ต์ถœํŒ๋ฌธํ™”์›)์˜ ์ œ10์žฅ์„ ์ €์ž๊ฐ€ ์š”์•ฝ ๋ฐœ์ทŒํ•˜์—ฌ ์ž‘์„ฑ๋˜์—ˆ๋‹ค.ํ˜‘๋™์กฐํ•ฉ์€ ๊ฐœ๋„๊ตญ์€ ๋ฌผ๋ก  ์„ ์ง„๊ตญ์—์„œ๋„ ๊ณ ์šฉ์ œ๊ณต ๋ฐ ์œ ์ง€, ๊ณต์ •ํ•œ ๋ถ€์˜ ์žฌ๋ถ„๋ฐฐ ์‹คํ˜„ ๋“ฑ ์‚ฌํšŒ ๋ฐ ๊ฒฝ์ œ์˜ ์ง€์†์  ๋ฐœ์ „์— ์ค‘์š”ํ•œ ์กฐ์งํ˜•ํƒœ์ด๋‹ค. ์ „ ์„ธ๊ณ„์ ์œผ๋กœ 10์–ต๋ช… ์ด์ƒ์ด ์กฐํ•ฉ์›์ด๋ฉฐ, ์ „ ์„ธ๊ณ„ ์ธ๊ตฌ์˜ ์ ˆ๋ฐ˜์ด์ƒ์ธ 30์–ต ๋ช… ์ด์ƒ์ด ํ˜‘๋™์กฐํ•ฉ(๊ธฐ์—…)์˜ ์˜ํ–ฅ์„ ๋ฐ›๊ณ  ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ์ถ”์ •๋œ๋‹ค. ํŠนํžˆ, 08๋…„ ์„ธ๊ณ„๊ฒฝ์ œ ์œ„๊ธฐ ์‹œ ์œ ๋Ÿฝ์—์„œ ํ˜‘๋™์กฐํ•ฉ๋“ค์˜ ํšจ๊ณผ์  ๋Œ€์‘์ด ํ™•์ธ๋จ์— ๋”ฐ๋ผ ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ํ˜‘๋™์กฐํ•ฉ์˜ ์ž ์žฌ์  ๊ฐ€๋Šฅ์„ฑ์— ๋Œ€ํ•ด ์žฌ์ธ์‹ํ•˜๊ณ  ์žˆ๋‹ค. 08๋…„ ๊ธˆ์œต์œ„๊ธฐ์— ๋”ฐ๋ฅธ ๋Œ€๋Ÿ‰ํ•ด๊ณ ๊ฐ€ ์›”๊ฐ€๋ฅผ ๋ฎ์ณค์„ ๋•Œ ์ดํƒˆ๋ฆฌ์•„ ๊ฒฝ์šฐ ๊ฐ™์€ ์‹œ๊ธฐ 8,000๊ฐœ ํ˜‘๋™์กฐํ•ฉ์—์„œ ๋‹จ 1๋ช…๋„ ํ•ด๊ณ ํ•˜์ง€ ์•Š์•˜๋‹ค. ์šฐ๋ฆฌ์˜ ๊ฒฝ์šฐ๋„ ๊ณ ์šฉ์ฐฝ์ถœ์„ ๊ธฐ๋Œ€ํ•˜๋ฉด์„œ ์ œ์ •ยท์‹œํ–‰๋œ ํ˜‘๋™์กฐํ•ฉ๊ธฐ๋ณธ๋ฒ•์— ๊ทผ๊ฑฐํ•œ ํ˜‘๋™์กฐํ•ฉ์ด ๋ฒ• ์‹œํ–‰ 1๋…„ ์—ฌ ๋งŒ์ธ ์ง€๋‚œ 10์›” ๋ง ํ˜„์žฌ 2,851๊ฐœ๊ฐ€ ์„ค๋ฆฝ๋˜์–ด ํ˜‘๋™์กฐํ•ฉ์— ๋Œ€ํ•œ ์‹œ์žฅ์˜ ๊ธฐ๋Œ€๊ฐ€ ๋งค์šฐ ํผ์„ ์•Œ ์ˆ˜ ์žˆ๋‹ค. ์ด์— ๋”ฐ๋ผ ์„ ์ง„๊ตญ์˜ ์„ ํ–‰์—ฐ๊ตฌ๊ณ ์ฐฐ์„ ํ†ตํ•˜์—ฌ ๊ฒฝ์ œ๋ฐœ์ „๊ณผ์ •์—์„œ ํ˜‘๋™์กฐํ•ฉ์˜ ์—ญํ• ์„ ์•Œ์•„๋ณด๊ณ , ํ˜„์žฌ ์šฐ๋ฆฌ๋‚˜๋ผ ํ˜‘๋™์กฐํ•ฉ ๋ฐ ๊ด€๋ จ์ •์ฑ…์˜ ๋ฌธ์ œ์ ์„ ์‚ดํŽด๋ณด๊ณ  ํ–ฅํ›„ ํ˜‘๋™์กฐํ•ฉ์˜ ์ •์ฑ…๋ฐฉํ–ฅ์— ๋Œ€ํ•˜์—ฌ ์ œ์–ธํ•˜๊ณ ์ž ํ•œ๋‹ค

    Development of Case Database and Conceptual Structural Design Method using Case-Based Reasoning for Tall Buildings

    Get PDF
    Conceptual structural design of tall buildings consists of selecting structural materials and form of a building and producing a preliminary dimensional layout. Key parameters of a building, such as height of the building, typical live load, wind velocity, design acceleration, maximum lateral deflection, span, and story height, are important factors in the conceptual design phase. Knowledge solutions from similar problems in the past can be used for defining and finding a solution to a design problem. CBR(Case-based reasoning) is a problem solving approach that uses past experience and is highly useful to finding solutions for similar problems. In this paper, the conceptual structural design method using CBR which is intended to assist engineers in the schematic phase of the structural design of tall buildings is introduced. Inductive retrieval method and nearest-neighbor retrieval method are used for selecting structural system and similar design case, respectively. This study presents a schematic design method based on CBR using design information of tall building as a solution for the preliminary conceptual design stage.1. ์„œ๋ก  = 1 1.1 ์—ฐ๊ตฌ์˜ ๋ฐฐ๊ฒฝ ๋ฐ ๋ชฉ์  = 1 1.2 ์—ฐ๊ตฌ ๋™ํ–ฅ = 3 1.3 ์—ฐ๊ตฌ๋ฒ”์œ„ ๋ฐ ๋ฐฉ๋ฒ• = 4 2. ์‚ฌ๋ก€๊ธฐ๋ฐ˜์ถ”๋ก ๊ธฐ๋ฒ• = 7 2.1 ์‚ฌ๋ก€๊ธฐ๋ฐ˜์ถ”๋ก ์˜ ๊ฐœ์š” = 7 2.2 ์‚ฌ๋ก€ ๊ธฐ๋ฐ˜ ์ถ”๋ก (Case-BasedReasoning)์˜ ํŠน์ง• = 8 2.2.1 ์‚ฌ๋ก€๊ธฐ๋ฐ˜์ถ”๋ก ์˜ ์žฅยท๋‹จ์  = 9 2.2.2 ์‚ฌ๋ก€ ๊ธฐ๋ฐ˜ ์ถ”๋ก ๊ณผ ๊ทœ์น™ ๊ธฐ๋ฐ˜ ์ถ”๋ก (๋‹ค๋ฅธ ์ธ๊ณต์ง€๋Šฅ๊ธฐ๋ฒ•)์˜ ์ฐจ์ด = 9 2.3 ์‚ฌ๋ก€ ๊ธฐ๋ฐ˜ ์ถ”๋ก (Case-BasedReasoning)์˜ ์ ˆ์ฐจ = 11 2.3.1 ์‚ฌ๋ก€์˜ ํ‘œํ˜„ = 11 2.3.2 ์‚ฌ๋ก€์˜ ์ƒ‰์ธ ๋ฐ ๊ฒ€์ƒ‰ = 12 2.3.3 ์‚ฌ๋ก€์˜ ์กฐํšŒ = 14 2.3.4 ์‚ฌ๋ก€์ ์‘(caseadaptation) = 17 3. ์‚ฌ๋ก€๊ธฐ๋ฐ˜์ถ”๋ก ๊ธฐ๋ฒ•์„ ์ด์šฉํ•œ ๊ฐœ๋…๊ตฌ์กฐ์„ค๊ณ„๋ฒ• = 19 3.1 ์ดˆ๊ณ ์ธต ๊ฑด๋ฌผ ๊ตฌ์กฐ์‹œ์Šคํ…œ์˜ ๋ถ„๋ฅ˜ = 19 3.2 ๊ตญ๋‚ด ์ดˆ๊ณ ์ธต๊ฑด๋ฌผ์˜ ์‚ฌ๋ก€๋ถ„์„ = 22 3.2.1 ๊ตญ๋‚ด์ดˆ๊ณ ์ธต๊ฑด๋ฌผ์˜ ๊ตฌ์กฐ์  ํŠน์„ฑ = 22 3.2.2 ๊ตญ๋‚ด์ดˆ๊ณ ์ธต๊ฑด๋ฌผ์˜ ํ˜„ํ™ฉ = 23 3.2.3 ์›น๊ธฐ๋ฐ˜ ์‚ฌ๋ก€ ๋ฐ์ดํ„ฐ(Case Data) ๊ตฌ์ถ• = 32 3.4 ๊ท€๋‚ฉ์  ์กฐํšŒ๊ธฐ๋ฒ• = 33 3.4.1 ํ•ด์•ˆ ์ง€์—ญ์˜ ์•Œ๊ณ ๋ฆฌ์ฆ˜ ๊ฐœ๋ฐœ = 33 3.4.2 ๋‚ด๋ฅ™ ์ง€์—ญ์˜ ์•Œ๊ณ ๋ฆฌ์ฆ˜ ๊ฐœ๋ฐœ = 39 3.5 ์ตœ๊ทผ๋ฆฐ ์กฐํšŒ๊ธฐ๋ฒ• = 46 3.5.1 ๊ฐ€์ค‘์น˜์— ๋”ฐ๋ฅธ ๊ฒฐ๊ณผ๊ฐ’์˜ ๋น„๊ต = 47 3.5.2 ๊ฐ€์ค‘์น˜์— ๋”ฐ๋ฅธ ์œ ์‚ฌ๋„์˜ ๋น„๊ต = 49 4. ์ดˆ๊ณ ์ธต ๊ฑด๋ฌผ ์ ์šฉ์˜ˆ์ œ = 53 4.1 ๊ท€๋‚ฉ์  ์กฐํšŒ๊ธฐ๋ฒ•์„ ์ด์šฉํ•œ ๊ตฌ์กฐ์‹œ์Šคํ…œ ์„ ์ • = 53 4.2 ์ตœ๊ทผ๋ฆฐ ์กฐํšŒ๊ธฐ๋ฒ•์„ ์ด์šฉํ•œ ์œ ์‚ฌ์„ค๊ณ„ ์‚ฌ๋ก€๋„์ถœ = 57 5. ๊ฒฐ๋ก  = 60 ์ฐธ๊ณ ๋ฌธํ—Œ = 6

    Trendelenburg position with hip flexion as a rescue strategy to increase spinal anaesthetic level after spinal block

    Get PDF
    BACKGROUND: When the level achieved by a spinal anaesthetic is too low to perform surgery, patients are usually placed in the Trendelenburg position. However, cephalad spread of the hyperbaric spinal anaesthetics may be limited by the lumbar lordosis. The Trendelenburg position with the lumbar lordosis flattened by hip flexion was evaluated as a method to extend the analgesic level after the administration of hyperbaric local anaesthetic. METHODS: When the pinprick block level was lower than T10 5 min after intrathecal injection of hyperbaric bupivacaine (13 mg), patients were recruited to the study and randomly allocated to one of the two positions: the Trendelenburg position with hip flexion (hip flexion group, n = 20) and the Trendelenburg position without hip flexion (control group, n = 20). Each assigned position was maintained for 5 min and then patients were returned to the horizontal supine position. Spinal block level was assessed by pinprick, cold sensation, and modified Bromage scale at intervals for the following 150 min. RESULTS: The maximum level of pinprick and cold sensory block [median (range)] was higher in the hip flexion group [T4 (T8-C6) and T3 (T6-C2)] compared with the control group [T7 (T12-T4) and T5 (T11-T3)] (P < 0.001). The maximum motor blockade median (range) was not different between the two groups being 3 (3-3) in the hip flexion group vs 3 (0-3) in the control group. CONCLUSIONS: When the level of spinal anaesthesia is lower than required, flexion of the hips in the Trendelenburg position may be useful as a strategy attempt to increase the level of the block.ope

    Analyses of the frequency and the indications of succinylcholine in general inhalation anesthesia

    Get PDF
    Background Succinylcholine (Sch) has been considered to be the neuromuscular blockade (NMB) of choice in clinical anesthesia due to its rapid onset and short duration of action. Despite these clinical advantages, the use of Sch has decreased recently on account of its potentially fatal adverse effects such as cardiac arrest and malignant hyperthermia. The aim of this report was to analyze the frequency and the indications of Sch as well as to discover an alternative to decreasing the frequency of Sch use. Methods The medical records of a total of 33,972 cases under general anesthesia were collected retrospectively, and the frequency of Sch use and the reason for choosing Sch was analyzed. The side effects and other complications of Sch were also analyzed. Results A muscle relaxant was administered in 32,724 cases (96.3%) out of 33,972 cases, and Sch was used in 647 of these cases (1.9%). The reasons for choosing Sch were the rapid sequence induction (291 cases), short operation time (220 cases), recent food intake (51 cases), habitual use (78 cases) and reintubation (7 cases). There were 211 cases of the single administration of Sch and 13 cases in whom Sch was injected repeatedly. A non-depolarizing muscle relaxant (NDMR) was used after Sch administration in 423 cases. Precurarization was carried out in 434 cases (67%) and no severe complications were observed. Conclusions The frequency of using Sch use can be decreased by reducing the habitual use and choosing the intubating dose of the intermediate acting NDMR as an alternative.ope

    Intravenous lidocaine prior to extubation reduces emergence agitation and cough in pediatric adenotonsillectomy under sevoflurane anesthesia

    Get PDF
    Background Sevoflurane is widely used to ambulatory pediatric anesthesia. But, sevoflurane is associated with a high incidence of emergence agitation in children. In this study, we examined the effect of single intravenous lidocaine prior to extubation on emergence agitation and cough in children undergoing adenotonsillectomy. Methods All patients received a standardized anesthetic regimen with 2-3% sevoflurane in 50% O2/N2O after anesthetic induction with intravenous glycopyrrolate 0.004 mg/kg, thiopental 5 mg/kg and vecuronium 0.1 mg/kg. In a double-blinded trial, 120 children (3-9 years) were randomly assigned to receive normal saline 0.1 ml/kg (Group C), 1% lidocaine 1 mg/kg (Group L1) or 2% lidocaine 2 mg/kg (Group L2), at 1 min after beginning of spontaneous respiration. After extubation, the sedation score and the incidence of agitation and cough were recorded. Results The incidence of agitation and cough in Group L1 and L2 were significantly less than Group C (P < 0.05). At 5 min after arrival at postanesthetic care unit (PACU), more patients in Group L1 and L2 were in deeper sedation (the sedation score โ‰ฅ 2) than Group C. More patients in Group L1 were in deeper sedation than Group L2 and C at 10 min after arrival at PACU. Conclusions We conclude that intravenous lidocaine prior to extubation reduces emergence agitation and cough after sevoflurane anesthesia in children undergoing adenotonsillectomy.ope

    Airway Management for General Anesthesia in a Patient with Severe Trismus due to Temporomandibular Joint Ankylosis

    Get PDF
    An ankylosis of temporomandibular joint (TMJ) can cause severe trismus, thus it may bring on many difficulties in airway management such as orotracheal intubation or laryngeal mask airway insertion. Such difficulties may cause serious complications related to airway management because the trismus due to ankylosis of TMJ can not be improved by administration of muscle relaxants or deep anesthesia in most cases.We report a case of nasotracheal intubation guided by a fiberoptic bronchoscope in a male patient with severe trismus due to TMJ ankylosis, who was scheduled for undergoing ophthalmic surgeryope

    Myoclonic Movements Occurred After Combined Spinal-Epidural Anesthesia

    Get PDF
    Two cases showed intermittent myoclonic movements in the lower extremities after receiving combined spinal-epidural anesthesia (CSE). Case 1: A 73-year-old female patient, underwent CSE, for a total knee replacement of right leg. Anesthesia was performed at L3/4 interspace with 2.0 ml of 0.5% tetracaine, mixed with normal saline and patient's own cerebrospinal fluid and epinephrine 1:200,000. Epidural catheter was inserted 3 cm-cephalad. Patient-controlled analgesia regimen was made with sufentanil 100 ug, 0.75% ropivacaine 30 ml, and naloxone 0.55 mg, with normal saline. The infusion regimen began at the end of the surgery, finished uneventfully after one and half hours. After 3 hours, the patient developed symmetric hip adductions of large amplitude and extensions of both legs for 2 to 3 seconds. Until valproate 800 mg was given, the movements repeated at 1 to 2 minute intervals for 3 hours. Case 2:The anesthesia and analgesia for 74-year-old female patient was done in similar fashion. Three hours after the end of operation, the patient showed myoclonic movements on right leg for about 30 seconds. The movements occurred at 2-3 minute intervals for the subsequent 2 hours and resolved spontaneously.ope

    optimal temperature of biofilm formation and comparison of inactivation effects according to materials

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๋†์—…์ƒ๋ช…๊ณผํ•™๋Œ€ํ•™ ๋†์ƒ๋ช…๊ณตํ•™๋ถ€, 2019. 2. ๊ฐ•๋™ํ˜„.Biofilms have emerged as problems in food industry because of ability to form on food or food-contact surface in various conditions when surface bacteria were not properly removed Staphylococcus aureus which is one of prevalent pathogens in food industry can develop biofilm structure onto abiotic surfaces, causing cross-contamination. In comparison to 15 and 25โ„ƒ which maintain relatively consistent population over 7.0 log CFU/cm2, cell population at 37โ„ƒ increased in day 1 followed by constant decline. Thermal treatment inactivated 5-log population of biofilm cells when treated with 10 s at all conditions except for 25โ„ƒ in day 5. Also, when treated with non-thermal treatment, ca 1-log of biofilm cells was eliminated at 25โ„ƒ in day 5 while it resulted in over 2-log reduction in the other experimental conditions. To account for these phenomena, we conducted EPS quantification experiment using 96-well and stainless steel. In 96-well experiment, we found that highest amount of polysaccharide was secreted at the temperature of 25โ„ƒ, while total biomass and protein contents produced at 37โ„ƒ was greatest. However, previous studies show that main component for EPS secreted by S. aureus is polysaccharide. Thus, we could conclude that biofilm formed at 25โ„ƒ for 5 days exhibited highest resistance to thermal and nonthermal treatment due to enhanced ability for exopolysaccharide secretion. We investigated the effect of saturated steam (SS) at 100ยฐC and superheated steam (SHS) at 125ยฐC and 150ยฐC for inactivation of S. aureus biofilm in 4 types of coupons (STS No.4, STS 2B, HDPE, PP). We also identify material properties of each type of coupons to develop material factors affecting steam treatment. In all types of coupon, higher temperature and more superheated steam accomplished higher log reduction and need less time to reach below detection limit. S. aureus biofilm in steel type coupon is more susceptible than plastic type coupons under steam treatment. In this study two surface properties, which is roughness and hydrophobicity, did not have a significant effect on inactivation of biofilm in coupons by steam treatment. In contrast, thermal conductivity and thermal diffusivity had similar tendency of inactivation. S. aureus biofilm in higher thermal conductivity coupons were susceptible when steam was applied. Therefore, SHS treatment could be used to inactivate S. aureus biofilm in food-accessible surfaces and treatment time depended on the thermal conductivity of surfaces.ํ‘œ๋ฉด์— ์„ธ๊ท ์ด ์ ์ ˆํžˆ ์ œ๊ฑฐ ๋˜์ง€ ์•Š์•˜์„ ๊ฒฝ์šฐ, ๋‹ค์–‘ํ•œ ํ™˜๊ฒฝ ์กฐ๊ฑด์—์„œ๋„ ๊ท ์ด ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ํ˜•์„ฑํ•˜๋ฉฐ ํŠนํžˆ ์‹ํ’ˆ ์‚ฐ์—…์—์„œ ์‹ํ’ˆ์ด๋‚˜ ์‹ํ’ˆ ์ ‘์ด‰๋ฉด์— ํ˜•์„ฑํ•  ์ˆ˜ ์žˆ์–ด ๋ฌธ์ œ๋กœ ๋Œ€๋‘๋˜๊ณ ์žˆ๋‹ค. ์ด ๋•Œ, ์‹ํ’ˆ ์‚ฐ์—…์—์„œ ์ค‘์š”ํ•œ ๋ณ‘์›๊ท  ์ค‘ ํ•˜๋‚˜์ธ ํ™ฉ์ƒ‰ํฌ๋„์ƒ๊ตฌ๊ท ์€ ํ‘œ๋ฉด์— ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ํ˜•์„ฑํ•  ์ˆ˜ ์žˆ๋Š” ๋Œ€ํ‘œ๊ท  ์ค‘ ํ•˜๋‚˜ ์ด๋ฉฐ, ์ด์— ๋”ฐ๋ฅธ ๊ต์ฐจ ์˜ค์—ผ์˜ ์œ„ํ—˜์ด ์žˆ๋‹ค. ํ™ฉ์ƒ‰ํฌ๋„์ƒ๊ตฌ๊ท ์„ 15ยฐC, 25ยฐC ๊ทธ๋ฆฌ๊ณ  37ยฐC ์—์„œ 5์ผ ๋™์•ˆ ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ํ˜•์„ฑ์‹œํ‚ค๋ฉด์„œ ๊ท ์˜ ์ˆ˜ ๋ณ€ํ™”๋ฅผ ํ™•์ธํ•œ ๊ฒฐ๊ณผ, 15ยฐC๋‚˜ 25ยฐC์—์„œ๋Š” 7.0 log CFU/cm2์ด์ƒ์˜ ์ƒ๋Œ€์ ์œผ๋กœ ์ผ์ •ํ•œ ๊ฐ’์„ ๊ฐ€์ง€๋ฉฐ, 37ยฐC์—์„œ๋Š” 1์ผ ์งธ์— ํญ๋ฐœ์ ์œผ๋กœ ์ฆ๊ฐ€ํ•˜์ง€๋งŒ ๊ทธ ์ดํ›„ ๊ณ„์† ๊ฐ์†Œํ•˜์˜€๋‹ค. ์ฆ๊ธฐ์ฒ˜๋ฆฌ๋กœ ์—ด ์ €ํ•ญ์„ฑ์„ ํ™•์ธํ•œ ๊ฒฐ๊ณผ, 5์ผ ์ฐจ์— 25ยฐC๋ฅผ ์ œ์™ธํ•œ ๋ชจ๋“  ์กฐ๊ฑด์—์„œ 10 ์ดˆ๊ฐ„ ์ฒ˜๋ฆฌํ•˜์˜€์„ ๋•Œ, 5 ๋กœ๊ทธ ์ด์ƒ ๊ท ์ด ์ €๊ฐํ™” ๋˜์—ˆ๋‹ค. ๋˜ํ•œ ์ฐจ์•„์—ผ์†Œ์‚ฐ๋‚˜ํŠธ๋ฅจ 10 ppm์œผ๋กœ ๋น„ ์—ด์ฒ˜๋ฆฌ๋ฅผ ํ•˜์˜€์„ ๋•Œ, 25ยฐC์—์„œ๋Š” ์•ฝ 1 ๋กœ๊ทธ์˜ ๊ท  ์ €๊ฐํ™”๋ฅผ ๋ณด์˜€์ง€๋งŒ ๋‚˜๋จธ์ง€ ์กฐ๊ฑด์—์„œ๋Š” 2 ๋กœ๊ทธ ์ด์ƒ์ด ์ €๊ฐํ™” ๋˜์—ˆ๋‹ค. ์ด๋Ÿฌํ•œ ํ˜„์ƒ์„ ์„ค๋ช…ํ•˜๊ธฐ ์œ„ํ•ด 96-well ์‹คํ—˜์—์„œ 25ยฐC์—์„œ ๋‹ค๋‹น๋ฅ˜์˜ ๋ถ„๋น„๋Ÿ‰์ด ๊ฐ€์žฅ ๋งŽ์•˜์œผ๋ฉฐ, 37ยฐC์—์„œ๋Š” ์ƒ์‚ฐ๋œ ์ด ๋ฐ”์ด์˜ค๋งค์Šค์™€ ๋‹จ๋ฐฑ์งˆ์˜ ํ•จ๋Ÿ‰์ด ๊ฐ€์žฅ ๋†’์•˜๋‹ค. ํ•˜์ง€๋งŒ ์ด์ „ ์—ฐ๊ตฌ์—์„œ๋„ ๋ฐํ˜€์ง„ ๋ฐ”๋กœ๋Š” ํ™ฉ์ƒ‰ํฌ๋„์ƒ๊ตฌ๊ท ์ด ๋ถ„๋น„ํ•˜๋Š” EPS์˜ ์ฃผ์„ฑ๋ถ„์ด ๋‹ค๋‹น๋ฅ˜์˜€๋‹ค. ๋”ฐ๋ผ์„œ ์šฐ๋ฆฌ๋Š” 25ยฐC์—์„œ 5์ผ ๋™์•ˆ ํ˜•์„ฑ๋œ ๋ฐ”์ด์˜คํ•„๋ฆ„์ด ์™ธ๋ถ€์— ๋‹ค๋‹น๋ฅ˜๋ฅผ ๊ฐ€์žฅ ๋งŽ์ด ๋ถ„๋น„ํ•˜์—ฌ ์™ธ๋ถ€ ์ž๊ทน์— ๋Œ€ํ•œ ์ €ํ•ญ์„ฑ์„ ๊ฐ–์ถ˜ ๊ฒƒ์ด๋ผ๊ณ  ํ•ด์„ํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด์–ด ์šฐ๋ฆฌ๋Š” 4 ์ข…๋ฅ˜์˜ ์ฟ ํฐ (์Šคํ…Œ์ธ๋ฆฌ์Šค ๊ฐ• No.4, ์Šคํ…Œ์ธ๋ฆฌ์Šค ๊ฐ• 2B, ๊ณ ๋ฐ€๋„ ํด๋ฆฌ์—ํ‹ธ๋ Œ, ํด๋ฆฌํ”„๋กœํ•„๋ Œ)์—์„œ ํ™ฉ์ƒ‰ํฌ๋„์ƒ๊ตฌ๊ท ์ด ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ํ˜•์„ฑํ•˜์˜€์„ ๋•Œ ์ด๋ฅผ 100ยฐC์˜ ํฌํ™” ์ฆ๊ธฐ์™€ 125ยฐC, 150ยฐC์˜ ์ดˆ๊ณ ์˜จ ๊ณผ์—ด ์ฆ๊ธฐ๋กœ ๋ถˆํ™œ์„ฑํ™”ํ•˜๋Š” ์‹คํ—˜์„ ์ง„ํ–‰ํ•˜์˜€๋‹ค. ๋˜ํ•œ ์ฆ๊ธฐ ์ฒ˜๋ฆฌ์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๋ฌผ์งˆ์ ์ธ ์š”์ธ์„ ๋ฐํžˆ๊ธฐ ์œ„ํ•ด ๊ฐ ์œ ํ˜•์˜ ์ฟ ํฐ์— ๊ฑฐ์น ๊ธฐ์™€ ์†Œ์ˆ˜์„ฑ ๊ทธ๋ฆฌ๊ณ  ์—ด์ „๋„๋„๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. ๋ชจ๋“  ์ข…๋ฅ˜์˜ ์ฟ ํฐ์—์„œ ๋” ๋†’์€ ์˜จ๋„์™€ ๋” ๋งŽ์ด ๊ณผ์—ด๋œ ์ฆ๊ธฐ๊ฐ€ ๋†’์€ ๊ท ์˜ ๋กœ๊ทธ ์ €๊ฐํ™”๋ฅผ ๋ณด์˜€๊ณ  ๊ฒ€์ถœ ํ•œ๊ณ„ ์ดํ•˜๋กœ ๋„๋‹ฌํ•˜๋Š”๋ฐ ๊ฑธ๋ฆฌ๋Š” ์‹œ๊ฐ„ ๋˜ํ•œ ์งง์•˜๋‹ค. ์ฆ๊ธฐ ์ฒ˜๋ฆฌ๋ฅผ ์Šคํ‹ธ ๊ณ„์—ด์˜ ์ฟ ํฐ์—์„œ ํ˜•์„ฑ๋œ ๋ฐ”์ด์˜คํ•„๋ฆ„์— ํ•˜๋Š” ๊ฒƒ์ด ํ”Œ๋ผ์Šคํ‹ฐ ๊ณ„์—ด์˜ ์ฟ ํฐ๋ณด๋‹ค ๋‚ด๋ถ€์˜ ๊ท ์„ ๋” ๋น ๋ฅด๊ฒŒ ์ €๊ฐํ™” ํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์—์„œ ํ‘œ๋ฉด์˜ ๊ฑฐ์น ๊ธฐ์™€ ์†Œ์ˆ˜์„ฑ์€ ์ฆ๊ธฐ ์ฒ˜๋ฆฌ๋กœ ์ฟ ํฐ์œ„์— ํ˜•์„ฑ๋œ ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ๋ถˆํ™œ์„ฑํ™”ํ•˜๋Š”๋ฐ ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š์•˜๋‹ค. ๋ฐ˜๋ฉด, ์—ด์ „๋„๋„๋‚˜ ์—ดํ™•์‚ฐ์œจ์€ ์ฆ๊ธฐ๋กœ ์—ฌ๋Ÿฌ ์žฌ์งˆ์œ„์˜ ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ์ œ์–ดํ•˜๋Š” ๊ฒƒ๊ณผ ๊ฐ€์žฅ ์œ ์‚ฌํ•œ ๊ฒฝํ–ฅ์„ ๋ณด์˜€๋‹ค. ๋†’์€ ์—ด์ „๋„๋„๋ฅผ ๊ฐ€์ง„ ์ฟ ํฐ์ผ์ˆ˜๋ก ์ €๊ฐํ™” ํšจ๊ณผ๊ฐ€ ๋” ์ž˜ ์ผ์–ด๋‚ฌ๋‹ค. ๋ผ์„œ ํ™ฉ์ƒ‰ํฌ๋„์ƒ๊ตฌ๊ท ์ด ๋ฐ”์ด์˜คํ•„๋ฆ„์„ ํ˜•์„ฑํ•˜์—ฌ ์ด๋ฅผ ์ œ์–ดํ•  ๋•Œ ์ดˆ๊ณ ์˜จ ๊ณผ์—ด์ฆ๊ธฐ๋ฅผ ํ™œ์šฉํ•  ์ˆ˜ ์žˆ๊ณ , ๊ทธ ์ฒ˜๋ฆฌ์‹œ๊ฐ„์€ ์—ด์ „๋„๋„์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์งˆ ์ˆ˜ ์žˆ๋‹ค.I. INTRODUCTION 1 II. MATERIALS AND METHODS. 6 2.1. Bacterial cultures and cell suspension 6 2.2. Optimal conditions for biofilm formation depending on temperature 7 2.2.1. Coupons preparation. 7 2.2.2. Biofilm formation assay. 7 2.2.3. Steam treatment (thermal resistance) 8 2.2.4. NaOCl treatment (non-thermal resistance). 9 2.2.5. Bacterial enumeration. 9 2.2.6. EPS quantification 10 2.3. Comparison of S. aureus in biofilm reduction on 4 types of food contact surface 11 2.3.1. Coupons preparation 11 2.3.2. Biofilm formation assay 12 2.3.3. Saturated steam (SS) and superheated steam (SHS) treatment 12 2.3.4. Bacterial enumeration 13 2.3.5. Surface hydrophobicity and roughness measurement 14 2.3.6. Thermal conductivity and Thermal diffusivity measurement. 15 2.4. Statistical analysis. 15 III. RESULTS 16 3.1. Optimal conditions for biofilm formation depending on temperature 16 3.1.1. biofilm maturation curve. 16 3.1.2. Comparison of heat resistance of S. aureus in biofilm 18 3.1.3. Comparison of chemical resistance of S. aureus in biofilm. 22 3.1.4. Changes in EPS amount as the S. aureus biofilm maturated. 25 3.2. Inactivation of S. aureus biofilm on the food contact surfaces by superheated steam treatment 27 3.2.1. Superheated steam and saturated steam treatment on S. aureus biofilm on 4 types of coupons. 27 3.2.2. Material properties of coupons 33 IV. DISCUSSIONS. 35 V. REFERENCES. 44 VI. ๊ตญ๋ฌธ์ดˆ๋ก 56Maste
    • โ€ฆ
    corecore